Position in HALO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,682,188
+$3,627,276 QoQ
Shares Held
238,689
+2.5% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#86
of 667 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026South Street Advisors LLC holds $40,957,206 across 2 Biotechnology names. HALO ranks #2 (45.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
409,392 | $22,275,018 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
238,689 | $18,682,188 |
All Filings in HALO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,682,188 | 238,689 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $15,054,912 | 232,940 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,597,313 | 231,758 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $18,177,465 | 247,852 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,550,761 | 241,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,544,754 | 243,610 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,985,064 | 229,765 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,811,794 | 171,415 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||